Crossmark

Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland

Crossref DOI link: https://doi.org/10.1007/s12325-020-01398-8

Published Online: 2020-06-09

Published Print: 2020-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Soini, Erkki https://orcid.org/0000-0003-4259-7610
Virtanen, Outi

Väätäinen, Saku

Briere, Jean-Baptiste https://orcid.org/0000-0002-3925-7677
Bowrin, Kevin

Millier, Aurelie
Funding

Funding for this research was provided by:

Bayer Oy
License Information

Text and Data Mining valid from 2020-06-09

Version of Record valid from 2020-06-09
More Information

Article History

Received: 14 April 2020

First Online: 9 June 2020